🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, double-blind, placebo-controlled Phase 3...
Status
Not Yet Recruiting
Location
Peking University First Hospital
Start Date
2026-08
Trial ID
NCT07680829
DR10624 is an Fc fusion protein tri-agonist with balanced glucagon-like pep...
Status
Completed
Location
New Zealand Clinical Research
Start Date
2022-06-22
Trial ID
NCT05378893
Treatments Being Tested
DR10624 is an Fc fusion protein tri-agonist with balanced glucagon-like pep...
Status
Completed
Location
Baoding No.1 Central Hospital
Start Date
2024-08-01
Trial ID
NCT06555640
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled Phase 3...
Status
Not Yet Recruiting
Location
Zhongshan Hospital
Start Date
2026-08-17
Trial ID
NCT07693777
Treatments Being Tested
This is a researcher-initiated study to evaluate the effect of DR10624 inje...
Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Anhui Medicaluniversity
Start Date
2025-07-01
Trial ID
NCT07050134
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Hangzhou Normal University
Start Date
2025-04-22
Trial ID
NCT07024212
Treatments Being Tested